Current:Home > StocksThis cellular atlas could lead to breakthroughs for endometriosis patients -Global Capital Summit
This cellular atlas could lead to breakthroughs for endometriosis patients
View
Date:2025-04-13 10:36:00
Dr. Kate Lawrenson's research is granular. As a professor of obstetrics and gynecology and co-director of the Women's Cancer Research program at Cedars-Sinai, she spends her days analyzing individual cells. It may sound tedious, but it's this kind of fine grain work that's led to many breakthroughs in cancer research.
Lawrenson hopes that this approach will lead to breakthroughs in a different disease — endometriosis. Endometriosis is caused by endometrial tissue growing outside of the uterus. It affects more than 10% of reproductive-aged women, is a major cause of infertility and can increase a person's risk for ovarian cancer.
Despite being incredibly common, endometriosis remains a mystery to researchers. So much so that diagnosis can take years. Even then, there's currently no cure for endometriosis, only treatments to manage the symptoms.
However, with the help of single-cell genomics technology, Kate Lawrenson and her team of researchers are paving the way for a brighter future for endometriosis patients. They've created a cellular atlas—essentially a cell information database—to serve as a resource for endometriosis research. To do this, the team analyzed nearly 400,000 individual cells from patients.
"This has been a real game changer for diseases such as endometriosis, where there are lots of different cell types conspiring to cause that disease," Lawrenson said. She and her team hope that this molecular information could lead to better, quicker diagnoses, as well as identify the patients who are most at risk.
Because of the lack of data and understanding around endometriosis, the disease has historically yielded stories of undiagnosed cases and patients being "medically gaslit," meaning their symptoms are dismissed or minimized by health care providers.
But Dr. Lawrenson says that these days, she's noticing more discussion of endometriosis and other diseases that have historically received lower research funding among her peers, by medical institutions and in popular media. She senses a changing tide in the way health care professionals think about and study endometriosis. "I've been in research for, I think, 18 years now, and I've seen a big change in that time. So hopefully the next 18 years will really see differences in how we understand and we process and how we can treat it more effectively and diagnose it more efficiently," she said.
This episode was produced by Margaret Cirino and Carly Rubin. It was edited by managing producer Rebecca Ramirez and Willa Rubin. It was fact-checked by Will Chase. Gilly Moon was the audio engineer.
veryGood! (77)
Related
- Could Bill Belichick, Robert Kraft reunite? Maybe in Pro Football Hall of Fame's 2026 class
- Zenith Asset Investment Education Foundation: Pioneering Financial Literacy and Growth
- Unveiling the Builders Legacy Advance Investment Education Foundation: Empowering Investors for Financial Mastery
- MLB All-Star Game: Rookie pitchers to start Midseason classic
- FACT FOCUS: Inspector general’s Jan. 6 report misrepresented as proof of FBI setup
- More than 2 dozen human skeletons dating back more than 1,000 years found in hotel garden
- Celtics' star Jaylen Brown backtracks on apparent criticism of Bronny James
- Anger over Houston power outages after Beryl has repair crews facing threats from some residents
- Former longtime South Carolina congressman John Spratt dies at 82
- Alicia Keys Shares Her Beauty Rituals, Skincare Struggles, and Can’t-Miss Amazon Prime Day 2024 Deals
Ranking
- Louvre will undergo expansion and restoration project, Macron says
- Unveiling the Zenith Asset Investment Education Foundation: Empowering Investors for Financial Mastery
- Johnny Depp Is Dating Model Yulia Vlasova
- What is 'Hillbilly Elegy' about? All about JD Vance's book amid VP pick.
- What were Tom Selleck's juicy final 'Blue Bloods' words in Reagan family
- Jennifer Aniston’s Go-to Vital Proteins Collagen Powder Is on Sale for Only $17 During Prime Day
- Strategic Uses of Options in Investment: Insights into Hedging Strategies and Value Investing
- The billionaire who fueled JD Vance's rapid rise to the Trump VP spot — analysis
Recommendation
'Survivor' 47 finale, part one recap: 2 players were sent home. Who's left in the game?
Unveiling the Builders Legacy Advance Investment Education Foundation: Empowering Investors for Financial Mastery
Jennifer Aniston’s Go-to Vital Proteins Collagen Powder Is on Sale for Only $17 During Prime Day
Michael D.David: Stock options notes 3
Juan Soto praise of Mets' future a tough sight for Yankees, but World Series goal remains
Bears finally come to terms with first-round picks, QB Caleb Williams and WR Rome Odunze
Exploring the 403(b) Plan: Quantum Prosperity Consortium Investment Education Foundation Insights
Zenith Asset Investment Education Foundation: Empowering Investors Worldwide